www.dicardiology.com
Open in
urlscan Pro
2606:4700:4400::6812:20f5
Public Scan
Submitted URL: https://wainscot.omeclk.com/portal/wts/ucmcnt2cgDaq|Bqdm--cAcA-h
Effective URL: https://www.dicardiology.com/sites/default/files/newsletters/1652283820.html
Submission: On May 11 via api from US — Scanned from DE
Effective URL: https://www.dicardiology.com/sites/default/files/newsletters/1652283820.html
Submission: On May 11 via api from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Heart failure patients implanted with Barostim can now receive conditional MRI scans Problem viewing this email? View it in your browser. May 11, 2022 / Dicardiology.com CVRx Receives MR-conditional Labeling Approval for its Barostim Heart Failure System CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has received U.S. Food and Drug Administration (FDA) approval for magnetic resonance conditional labeling for its Barostim System. Read More FARXIGA Met Primary Endpoint in DELIVER Phase III Trial High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a statistically significant and clinically meaningful reduction in the primary composite endpoint of cardiovascular (CV) death or worsening heart failure (HF). Read More WLNC Highlights Q Catheter Compatibility in Simulated Robotic Thrombectomy The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot. Read More Cardiovascular Ultrasound Market Forecast The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period, according to The Cardiovascular Ultrasound System Market—Growth, Trends, COVID-19 Impact and Forecast (2022-2027), a new report from Mordor Intelligence. Read More Mayo Researchers Use AI to Detect Weak Heart Pump via Patients’ Apple Watch ECGs Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump. Read More For more news and videos, visit the DAIC website at www.DIcardiology.com CUSTOM COMPARISON CHARTS Interested in create a custom comparison chart for your specific research needs? Check out our website for more information. GET THE LATEST IN INDUSTRY NEWS AND TRENDS Subscribe to the magazine CONTACT US Diagnostic and Interventional Cardiology Offices One Maynard Drive, Park Ridge, NJ 07656 (201) 571-2244 | www.dicardiology.com | Email us